Blog

Discussing key developments in haemato-oncology from the 66th ASH Annual Meeting – SPCC

SPCC/LinkedIn

Dec 1, 2024, 21:20

Discussing key developments in haemato-oncology from the 66th ASH Annual Meeting – SPCC

SPCC (Sharing Progress in Cancer Care) shared a post on LinkedIn:

“Join our live webinar as we discuss key developments in haemato-oncology from the 66th ASH Annual Meeting!

This is your chance to explore critical topics such as stem cell transplantation in leukaemia and bone marrow failure, and engage with experts in the field during the final Q&A session.

Speakers: Jakob Passweg, David Gómez-Almaguer, Phillip Scheinberg

18 December 2024 – 18:00 CET
Register now.

This activity is supported by educational grants from Cloud Pathology Group and Eli Lilly and Company. The companies have no control over its content.”

More posts featuring SPCC.

66th ASH Annual Meeting cancer David Gomez-Almaguer haemato-oncology Jakob Passweg OncoDaily Oncology Phillip Scheinberg Sharing Progress in Cancer Care SPCC

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage